High-Volume Centers Provide Superior Value of Care in the Surgical Treatment of Malignant Brain Tumor

Vazquez, Sima; Dominguez, Jose F.; Wu, Eva; Spirollari, Eris; Soldozy, Sauson; Ivan, Michael E.; Merenzon, Martin; Hanft, Simon J.; Komotar, Ricardo J.

doi:10.1016/j.wneu.2024.01.030

World Neurosurgery

2024

DOI: 10.1016/j.wneu.2024.01.030

|View full text |Cite

High-Volume Centers Provide Superior Value of Care in the Surgical Treatment of Malignant Brain Tumor

Sima Vazquez,

Jose F. Dominguez,

Eva Wu

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Relapse and survival after relapse among children with cancer in Denmark: 2001–2021

Andersen,

Sørensen,

Schmiegelow

et al. 2024

Pediatric Blood & Cancer

View full text Add to dashboard Cite

BackgroundIn recent decades, new first and subsequent lines of anticancer treatment and supportive care have improved survival for children with cancer. We investigated recent temporal changes in the incidence of relapse and survival after relapse among children with cancer in Denmark.ProcedureThis register‐based study included 2890 children diagnosed before age 15 years with haematological cancers and solid tumours (2001–2021) and central nervous system (CNS) tumours (2010–2021). We used the Aalen–Johansen and Kaplan–Meier estimators to assess cumulative incidence of relapse—defined as cancer recurrence or progression—and survival probability after relapse.ResultsComparing the periods 2001–2010 and 2011–2021, the 5‐year cumulative incidence of relapse decreased from 14% to 11% among children with haematological cancers (p = .07), and from 21% to 18% among children with solid tumours (p = .26). Concurrently, the 5‐year survival after relapse increased among children with haematological cancers (from 44% to 61%, p = .03) and solid tumours (from 38% to 46%, p = .25). Among children with malignant CNS tumours, the 5‐year cumulative incidence of relapse and the 5‐year survival after relapse remained stable (49% and 51%, p = .82; and 20% and 18%, p = .90) comparing 2010–2015 and 2016–2021.ConclusionsIn recent decades in Denmark, improvements were observed in reducing relapse incidence and increasing survival after relapse in children with haematological cancers and solid tumours. However, the persistent survival gap between children who relapse and those who do not across all childhood cancers underlines the need for intensified and highly targeted treatments for children at high risk of relapse.

show abstract

Relapse and survival after relapse among children with cancer in Denmark: 2001–2021

Andersen,

Sørensen,

Schmiegelow

et al. 2024

Pediatric Blood & Cancer

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

High-Volume Centers Provide Superior Value of Care in the Surgical Treatment of Malignant Brain Tumor

Cited by 1 publication

References 38 publications

Relapse and survival after relapse among children with cancer in Denmark: 2001–2021

Relapse and survival after relapse among children with cancer in Denmark: 2001–2021

Contact Info

Product

Resources

About